Search for: "RANBAXY INC"
Results 41 - 60
of 142
Sort by Relevance
|
Sort by Date
23 Nov 2012, 10:40 am
Indian drugmaker Ranbaxy Laboratories said it issued the recall because of its generic version of Pfizer Inc.'s Lipitor because after it learned that some lots of its 10-, 20- and 40-milligram doses of the drug may contain glass. [read post]
12 Sep 2012, 5:00 am
Ranbaxy Pharmaceuticals, Inc., No. 3:11-cv-858-RCJ-VPC (D. [read post]
29 Aug 2012, 10:09 pm
., Inc. [read post]
29 Aug 2012, 3:15 am
Ranbaxy Pharmaceuticals, Inc., 336 F.3d 1322, 1330 (Fed. [read post]
15 Aug 2012, 11:02 am
District Court for the District of Columbia by Watson Laboratories, Inc. [read post]
16 Jul 2012, 12:10 pm
Ranbaxy Pharma. [read post]
8 Jul 2012, 1:58 pm
Ranbaxy has U.S. offices in Princeton, New Jersey. [read post]
27 Jun 2012, 5:38 am
That day has come with Sandoz Inc. [read post]
3 Mar 2012, 9:45 am
In an article titled Sector Snap: Generic competition and biotech drugs , one notes the irony that generic maker Teva is facing Hatch-Waxman challenges from Mylan Inc. and Novartis AG over its patented drug Copaxone, a drug for treatment of multiple sclerosis. [read post]
1 Feb 2012, 8:49 am
” Ranbaxy Pharm., Inc. v. [read post]
28 Jan 2012, 6:23 am
Any hopes that consumers of generic drugs would be protected by the FDA’s own oversight of generic drug manufacturing came to a crashing halt earlier this week when the Department of Justice and the Food and Drug Administration jointly announced their Consent Decree with Ranbaxy Laboratories: Through investigation by the department and the FDA, the government uncovered numerous problems with Ranbaxy’s drug manufacturing and testing in India and at facilities owned by… [read post]
1 Dec 2011, 3:58 am
Yes, Virginia, Ranbaxy Will Sell A Generic Lipitor Ranbaxy to Share Part of Lipitor Profits With Teva**UPDATE. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
22 Jul 2011, 12:31 pm
Ranbaxy Laboratories, Inc., No. 10-793 (E.D. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid… [read post]
30 Jun 2011, 9:18 pm
Munsingwear, Inc. that hold that courts should vacate judgments in a case that becomes moot unless the moving party's actions make vacatur inequitable. [read post]
27 Jun 2011, 4:00 am
Ranbaxy Pharmaceuticals, Inc. [read post]
16 May 2011, 9:07 am
Ranbaxy Pharms., Inc., 336 F.3d 1322, 1329-30 (Fed. [read post]
3 May 2011, 7:16 am
Mylan Pharmaceuticals Inc. has lost its bid in Washington federal court to force a U.S. [read post]
